Outsourcing

Sep 28, 2017
By BioPharm International Editors
KBI Biopharma, a biopharmaceutical contract development and manufacturing organization, will manufacture an antibody and a fusion protein developed by Heat Biologics’ subsidiary.
Sep 27, 2017
By BioPharm International Editors
Fresenius Kabi broke ground on a previously announced $250 million expansion of its Melrose Park, IL, manufacturing facility.
Sep 26, 2017
By BioPharm International Editors
ADC Bio announces plans to expand into clinical and commercial drug manufacturing for ADCs.
Sep 21, 2017
By BioPharm International Editors
Ajinomoto Althea opens manufacturing suites in new high potency and antibody drug conjugate commercial facility.
Sep 19, 2017
By BioPharm International Editors
The acquisition adds to Catalent’s capabilities in biologics development, analytical services, manufacturing, and finished product supply.
Sep 01, 2017
BioPharm International
Innovation speeds discovery, drives down costs, and improves productivity.
Aug 01, 2017
BioPharm International
Despite some progress, the industry is still in a wait-and-see mode regarding the administration, Congress, and FDA.
Jul 21, 2017
By BioPharm International Editors
Contract manufacturers await a promising pipeline of drug products to jump-start stagnant growth.
Jul 21, 2017
By BioPharm International Editors
Catalent Applied Drug Delivery Institute announced a partnership with Rutgers University to examine the challenges of pediatric drug formulation and delivery.
Jul 19, 2017
By BioPharm International Editors
The Bridgewater facility will provide a range of contract services for biopharmaceutical and pharmaceutical manufacturers, and also serve electronics chemicals suppliers.
native1_300x100
lorem ipsum